DCF — TERREBONNE GENERAL HEALTH SYSTEM
Enterprise Value: $-309.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-309.2M
Enterprise Value
$-99.3M
PV of Cash Flows
$-209.9M
PV of Terminal Value
$-338.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $237.5M | $-18.5M | -8.0% | $-28.5M | $-25.9M |
| Year 2 | $244.7M | $-16.6M | -7.0% | $-26.9M | $-22.2M |
| Year 3 | $252.0M | $-14.5M | -6.0% | $-25.2M | $-18.9M |
| Year 4 | $259.6M | $-13.7M | -5.0% | $-24.7M | $-16.8M |
| Year 5 | $267.3M | $-13.4M | -5.0% | $-24.7M | $-15.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-309.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$230.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0826953640826193
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5